Vir Biotechnology, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (3)

Latest Posts

About This Stock More About This Stock
E US Stock Market Weekly Review Aug. 31- Sept. 4, 2020
Article By: Stavros Georgiadis
Sunday, September 6, 2020 6:54 AM EST
After four weeks of consecutive gains, the US stock market declined with increased volatility, as September kicked in, a month which is considered to be a tough one for stocks historically.
In this article: KELYB, GOGO, TCON, VIR, KCAC, ADTX
Read
Vir Biotechnology Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Tuesday, July 7, 2020 3:11 PM EST
Vir Biotechnology, Inc., today announced the pricing of its previously announced underwritten public offering of 7,142,857 shares of its common stock at a price to the public of $42.00 per share.
In this article: VIR
Read
Volatile Week For Coronavirus Stocks: COVID Vaccines Are In Focus
Article By: Rod Raynovich
Sunday, June 28, 2020 1:41 PM EST
Friday was a risk-off day for biotech stocks as the XBI​ took a 3.28% hit on profit taking and concerns that the pandemic could drag on through the summer.
In this article: INO, NVAX, QDEL, XBI, MRNA, VIR, BNTX
Read
The Week Ahead In Biotech: Urogen FDA Decision, Amarin, J&J Earnings And More COVID-19 Updates
Article By: Benzinga
Sunday, April 12, 2020 1:22 PM EST
Biotech stocks moved higher last week along with the broader market. The week witnessed a few clinical readouts and pre-announcements that reflected the coronavirus (COVID-19) impact.
In this article: ABT, JNJ, ALNY, GILD, ISRG, AMRN, AXSM, SCYX, ASND, URGN, ITRM, OVID, VIR
Read
Week In Review: CICC Capital Closes $229 Million China Fund For Biologics
Article By: ChinaBio® Today
Saturday, February 29, 2020 1:50 PM EST
CICC Capital closed a $229 million investment fund for biologics, with investments coming mainly from Chinese organizations inside and outside the biopharma industry. Some of the money will go to companies making COVID-19 vaccines and therapies.
In this article: AZN, GSK, PFE, GILD, MRNA, BGNE, VIR
Read

Latest Tweets for $VIR

No tweets yet!